相似文献
1
A cross-sectional assessment of utilization of addiction treatment among injection drug users in Kabul, Afghanistan.
Subst Use Misuse. 2009;44(3):416-30. doi: 10.1080/10826080802347669.
2
Correlates of receptive and distributive needle sharing among injection drug users in Kabul, Afghanistan.
Am J Drug Alcohol Abuse. 2008;34(1):91-100. doi: 10.1080/00952990701764771.
3
Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Harm Reduct J. 2015 Oct 16;12:22. doi: 10.1186/s12954-015-0056-z.
4
Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.
Harm Reduct J. 2011 Aug 25;8:22. doi: 10.1186/1477-7517-8-22.
5
Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal.
Int J Drug Policy. 2016 Jul;33:75-82. doi: 10.1016/j.drugpo.2016.05.005. Epub 2016 May 17.
6
A qualitative assessment of injection drug use and harm reduction programmes in Kabul, Afghanistan: 2006-2007.
Int J Drug Policy. 2009 Mar;20(2):111-20. doi: 10.1016/j.drugpo.2007.11.022. Epub 2008 Jan 22.
7
Association between expatriation and HIV awareness and knowledge among injecting drug users in Kabul, Afghanistan: A cross-sectional comparison of former refugees to those remaining during conflict.
Confl Health. 2007 Mar 21;1:5. doi: 10.1186/1752-1505-1-5.
8
Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war.
Drug Alcohol Depend. 2003 Jul 20;71(1):17-24. doi: 10.1016/s0376-8716(03)00072-3.
9
Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
Harm Reduct J. 2016 Jun 21;13(1):21. doi: 10.1186/s12954-016-0110-5.
10
HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
Int J Drug Policy. 2010 Jan;21(1):56-63. doi: 10.1016/j.drugpo.2009.02.007. Epub 2009 Apr 22.
引用本文的文献
1
British South Asian and Muslim Community's Perceptions and Experiences of Addiction and Traditional Drug and Alcohol Treatment Services.
Int J Environ Res Public Health. 2024 Oct 10;21(10):1338. doi: 10.3390/ijerph21101338.
2
Understanding injecting drug use in Afghanistan: A scoping review.
Subst Abuse Treat Prev Policy. 2022 Sep 19;17(1):65. doi: 10.1186/s13011-022-00491-1.
3
Factors Associated with HIV Risk and Vulnerability Among Injecting Drug Users in Afghanistan: A Narrative Review.
HIV AIDS (Auckl). 2022 Jul 23;14:331-339. doi: 10.2147/HIV.S366970. eCollection 2022.
4
Determinants of health among people who use illicit drugs in the conflict-affected countries of Afghanistan, Colombia and Myanmar: a systematic review of epidemiological evidence.
Confl Health. 2022 Jul 7;16(1):39. doi: 10.1186/s13031-022-00467-9.
5
Successful testing and treating of HIV/AIDS in Indonesia depends on the addiction treatment modality.
J Multidiscip Healthc. 2012;5:329-36. doi: 10.2147/JMDH.S37625. Epub 2012 Dec 14.
6
Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.
Harm Reduct J. 2011 Aug 25;8:22. doi: 10.1186/1477-7517-8-22.
本文引用的文献
1
Complex emergencies, HIV, and substance use: no "big easy" solution.
Subst Use Misuse. 2006;41(10-12):1637-51. doi: 10.1080/10826080600848116.
2
Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.
Subst Use Misuse. 2006;41(6-7):777-813. doi: 10.1080/10826080600669579.
3
The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine.
Sex Transm Dis. 2006 Oct;33(10 Suppl):S89-102. doi: 10.1097/01.olq.0000221335.80508.fa.
4
Do drug users in China who frequently receive detoxification treatment change their risky drug use practices and sexual behavior?
Drug Alcohol Depend. 2006 Sep 1;84(1):114-21. doi: 10.1016/j.drugalcdep.2006.01.004. Epub 2006 Jan 26.
5
The HIV epidemic in China: history, response, and challenge.
Cell Res. 2005 Nov-Dec;15(11-12):825-32. doi: 10.1038/sj.cr.7290354.
6
Effectiveness of harm reduction programmes for injecting drug users in Dhaka city.
Harm Reduct J. 2005 Oct 25;2:22. doi: 10.1186/1477-7517-2-22.
7
Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study.
Harm Reduct J. 2005 Oct 7;2:19. doi: 10.1186/1477-7517-2-19.
8
Drug use and harm reduction in Afghanistan.
Harm Reduct J. 2005 Sep 7;2:13. doi: 10.1186/1477-7517-2-13.
9
The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus.
Addiction. 2004 Dec;99(12):1565-76. doi: 10.1111/j.1360-0443.2004.00899.x.
10
Opioid substitution and HIV/AIDS treatment and prevention.
Lancet. 2004;364(9449):1918-9. doi: 10.1016/S0140-6736(04)17490-4.
Zotero 插件